The results of this Oncotype DX test, combined with other features of the specific cancer, can help you make a more informed decision regarding treatment.
This test can provide new information to those eligible that will help you decide whether or not to have chemotherapy to treat early-stage, hormone-receptor-positive breast cancer. It can also be helpful in deciding on radiation therapy to treat Ductal Carcinoma in situ. To learn more about:
-Who is eligible for the Oncotype DX test
-How Oncotype DX works
-Other genomic tests
Click on the link below for the following article via www.breastcancer.org